Lupus nephritis: review of the literature.
Physicians in practice should be knowledgeable regarding several aspects of autoimmune disorders, especially systemic lupus erythematosus (SLE) and lupus nephritis. These disorders can present to the clinician's clinic and private office regardless of their specialty. This review will discuss various aspects of SLE, its mechanisms of disease, role of accelerated atherosclerosis, proinflammatory cytokines, and therapeutic approaches. The role of vascular endothelial growth factor in which and plasma levels have been associated with disease activity, classification of severity, and diagnosis of lupus nephritis is addressed. Current treatment options, prognosis, and future therapeutic approaches and common side effects are also discussed.
Adeel
A
Zubair
Marianne
M
Frieri
D016207:Cytokines / Q000378:metabolism; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D008181:Lupus Nephritis / Q000097:blood / Q000175:diagnosis / Q000276:immunology* / Q000628:therapy; D011379:Prognosis; D042461:Vascular Endothelial Growth Factor A / Q000097:blood
D016207:Cytokines; D042461:Vascular Endothelial Growth Factor A